SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-127697
Filing Date
2018-04-24
Accepted
2018-04-24 07:31:33
Documents
3
Period of Report
2018-06-08
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A d549092ddef14a.htm DEF 14A 527065
2 GRAPHIC g549092g20a94.jpg GRAPHIC 32470
3 GRAPHIC g549092pa1a.jpg GRAPHIC 4074
  Complete submission text file 0001193125-18-127697.txt   578713
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37449 | Film No.: 18770126
SIC: 2834 Pharmaceutical Preparations